Micro-X Limited (MX1) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is a Company that is engaged in design, development, manufacturing and commercialisation of imaging products for the global healthcare and security markets utilising Micro-X's proprietary cold cathode X-ray technology.
| ASX Code | MX1 |
| Website | http://www.micro-x.com |
| Industry/Sector | Health Care Equipment |
| Market Cap ($M) | 20 |
| MX1 Share Price | $0.027 |
| Day High | $0.027 |
| Day Low | $0.027 |
| Last Close | $0.027 |
| MX1 Share Price Movement | - ( No change ) |
Micro-X Limited (MX1) is held across 1 ETF spanning strategies that include health care equipment exposure . Its weighting in those funds means performance can have an outsized influence - when MX1 moves, funds like IMPQ that hold it can move with it.
For more concentrated exposure, ETFs such as IMPQ (eInvest Better Future (Managed Fund)) allocate about 0.2% to MX1 , while the average exposure across all 1 ETF that hold it is around 0.2% .
Last updated: ETF data and holdings as at 22 August 2026
How does holding Micro-X Limited (MX1) shares directly compare to ETFs that include it?
|
MX1 Direct
|
IMPQ
ASX |
|
|---|---|---|
| Holdings | 1 company | 41 holdings |
| MX1 Weight | 100% | 0.2% |
| Diversification | Single Stock | Broad |
| Annual Cost | Brokerage only | 0.89% p.a. |
| Approx. Yield | - | 2.09% |
| Star Ratings | - |
Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not MX1's direct yield. Annual cost uses each ETF's MER.
How a $10,000 investment in Micro-X Limited (MX1) one week ago compares with ETFs that hold it.
| Security | Investment type | Current price | 7-day price movement | Dollar change | Value today |
|---|---|---|---|---|---|
| Micro-X Limited (MX1) | Direct share | $0.027 | -3.57% | -$357 | $9,643 |
| eInvest Better Future (Managed Fund) (IMPQ) | Equity - Australia Small/Mid Cap | $4.310 | -1.37% | -$137 | $9,863 |
Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.
1 ETF hold Micro-X Limited (MX1).
| ETF | MX1 Weight | MER | Yield |
|---|---|---|---|
| eInvest Better Future (Managed Fund) (IMPQ) | 0.2% | 0.89% | 2.09% |
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from Micro-X Limited (MX1) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025A | -$13.90 | -$2.30 | 29.60% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | -$9.39 | -$1.80 | -18.10% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2023A | -$10.75 | -$2.20 | -41.60% | 0.00 | 0.00 | 0.00% | 0.0% |
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | ||
| Cochlear Limited (COH) | $8,948M | -0.3136 | 0.2540 | 0.0785 | 33.3098 | 26.5629 | 24.6296 | 2.52% | 2.62% | 2.85% |
| Fisher & Paykel Healthcare Corporation Limited (FPH) | $20,990M | 0.1388 | 0.1474 | 0.1882 | 54.0451 | 47.1007 | 39.6406 | 1.21% | 1.31% | 1.48% |
| Micro-X Limited (MX1) | $20M | 0.2955 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| ResMed Inc. (RMD) | $19,000M | 9.5922 | 0.0985 | 0.0886 | 20.8623 | 18.9916 | 17.4458 | 1.11% | 1.21% | 1.31% |
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | 2.39 | 0.00 |
| Market | 0.35 | 13.10 | 1.15 | 0.80 |
| Sector | 0.66 | 18.80 | 1.67 | 2.23 |
| Name | Position | Start Date |
|---|---|---|
| Mr James (Jim) White McDowell | Non-Executive Director | 1 Jan 2021 |
| Ms Ilona Meyer | Non-Executive Director | 7 Mar 2022 |
| Mr Andrew Hartmann | Non-Executive Director | 15 Dec 2022 |
| Mr Patrick Gerard O'Brien | Non-Executive Director, Non-Executive Chairman | 6 Aug 2015 |
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 24 Apr 2026 | O'BRIEN, Patrick | Issued | Indirect Shares | 2,500,000 | $0.080 | $200,000.000 |
| 8 May 2025 | MEYER, Ilona | Issued | Direct Shares | 357,143 | $0.070 | $25,000.000 |
| 8 May 2025 | HARTMANN, Andrew | Issued | Direct Shares | 357,143 | $0.070 | $25,000.000 |
See all changes in directors' interest & trades for Micro-X Limited (MX1) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
| Name | Position |
|---|---|
| Brian Gonzales | CEO Americas & Chief Scientific Officer |
| Brian Gonzales | Chief Executive Officer |
| Anthony Skeats | Chief Operating Officer |
| Richard Walter Willson | Company Secretary |
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Micro-X Limited (MX1). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 86,540,365 (12.97%) | Perennial Value Management Limited |
| 71,089,457 (10.95%) | Acorn Capital Limited |
| 54,130,053 (8.11%) | Varex Imaging Corporation |
| 45,152,777 (6.67%) | TIGA Trading Pty Ltd |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.